Market Place
Sourcing Support
CStone announces first patient dosed in China with BLU-667
12 Aug 2019 //
PR NEWSWIRE
Shrinking 60% of lung cancers, Blueprint`s RET drug poised for 2020 filing
04 Jun 2019 //
FIERCE BIOTECH
Bio Roundup: Amarin’s Stunner, Lung Cancer News, Data Dumps & More
28 Sep 2018 //
XCONOMY
Blueprint’s Tagrisso combination shows early promise in NSCLC
26 Sep 2018 //
FIERCE BIOTECH
Blueprint Medicines Announces P-o-C Data of BLU-667 and Osimertinib in NSCLC
25 Sep 2018 //
PR NEWSWIRE
Blueprint Medicines Announces Updated Data from Pha1 EXPLORER CTRLof Avapritinib
15 Jun 2018 //
PRESS RELEASE
Blueprint Medicines Initiates VOYAGER Ph3 Clinical Trial of Avapritinib
21 May 2018 //
PRESS RELEASE
Blueprint Medicines Pub in Cancer Discovery Highlights Preclinical BLU-667
15 Apr 2018 //
PRESS RELEASE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.